About Suppressor APC domain-containing protein 2
Suppressor APC domain-containing protein 2 (SAPCD2) is a protein
from Homo sapiens identified by UniProt accession
Q86UD0, 394 residues long.
MolForge cross-references it against 0 known binders and
51 disease associations.
Target properties
| Protein name | Suppressor APC domain-containing protein 2 |
| UniProt accession | Q86UD0 |
| Gene | SAPCD2 |
| Organism | Homo sapiens |
| Length | 394 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (51)
Diseases linked to this target (Open Targets).
- high density lipoprotein cholesterol measurement · score 0.20
- aspartate aminotransferase measurement · score 0.19
- colorectal carcinoma · score 0.07
- platelet count · score 0.07
- leukocyte count · score 0.06
- neoplasm · score 0.05
- non-small cell lung carcinoma · score 0.04
- monocyte count · score 0.03
- melanoma · score 0.03
- lung adenocarcinoma · score 0.03
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q86UD0-F1 | alphafold | PREDICTED | 67.95 | — |
Amino-acid sequence (394 residues)
MAGAAMAERG RVPPPAPAPS TEGLPRAFLQ SLRTLFDILD DRRRGCVHLR EIESRWQGTD ARELPRGVLE GLRQVAPASG YLTFERFVAG LRTSLLSADG GPRDPTRAPA RPGDQPPPPP QRLVFAPADE PRTVLERKPL PLGVRAPLAG PSAAARSPEQ LCAPAEAAPC PAEPERSQSA ALEPSSSADA GAVACRALEA DSGDARRAPR ARGERRRHTI ASGVDCGLLK QMKELEQEKE VLLQGLEMMA RGRDWYQQQL QRVQERQRRL GQSRASADFG AAGSPRPLGR LLPKVQEVAR CLGELLAAAC ASRALPPSSS GPPCPALTST SPPVWQQQTI LMLKEQNRLL TQEVTEKSER ITQLEQEKSA LIKQLFEARA LSQQDGGPLD STFI
Explore Suppressor APC domain-containing protein 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets